Date: 2015-04-08
Type of information: Nomination
Compound:
Company: PTC Therapeutics (USA - NJ)
Therapeutic area: Neuromuscular diseases - Rare diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On April 8, 2015, PTC Therapeutics announced the appointment of Eric Pauwels as Senior Vice President and General Manager Commercial Operations, Americas. Eric will be responsible for the commercial strategy, organizational build out and launch of Translarna in the US, Canada and Latin America.Most recently, Eric was the Chief Commercial Officer at NPS Pharmaceuticals and President of NPS Pharmaceuticals International. At NPS, Eric built global commercial operations for the launch of Gattex/Revestive and prepared the pre-launch strategy for Natpara, both orphan biological therapies approved by the FDA for patients suffering from rare gastrointestinal and endocrine diseases. From 2005 to 2010, Eric served as Senior Vice President, Global Commercial Operations, at Shire Human Genetic Therapies, with oversight of more than 400 employees in 30 countries and $800 million in revenues. Eric also held global marketing and general management functions in the US, Europe and China with Shire, Bayer, Fournier and J&J. Eric holds a BSc. degree from California State Polytechnic University.
Financial terms:
Latest news:
